NASDAQ: EVAX
Evaxion A Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their EVAX stock forecasts and price targets.

Forecast return on equity

Is EVAX forecast to generate an efficient return?

Company
223.14%
Industry
43.27%
Market
164.09%
EVAX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is EVAX forecast to generate an efficient return on assets?

Company
109.74%
Industry
21.27%
EVAX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

EVAX earnings per share forecast

What is EVAX's earnings per share in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
-$0.57
Avg 2 year Forecast
-$1.11
Avg 3 year Forecast
-$0.61

EVAX revenue forecast

What is EVAX's revenue in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$0.0-100%
Avg 2 year Forecast
$0.0-100%
Avg 3 year Forecast
$10.5M+39.9%
EVAX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

EVAX revenue growth forecast

How is EVAX forecast to perform vs Biotechnology companies and vs the US market?

Company
4.1%
Industry
31.63%
Market
12.01%
EVAX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
EVAX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

EVAX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
EVAX$2.78N/AN/A
BYSI$0.56N/AN/A
CUE$2.83$83.00+2,832.86%Strong Buy
CRVO$1.50$21.50+1,333.33%Strong Buy
PLRZ$10.65N/AN/A

Evaxion A Stock Forecast FAQ

What is EVAX's earnings growth forecast for 2026-2028?

(NASDAQ: EVAX) Evaxion A's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.17%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33%.

Evaxion A's earnings in 2026 is -$8,655,000.On average, 6 Wall Street analysts forecast EVAX's earnings for 2026 to be -$239,614,380, with the lowest EVAX earnings forecast at -$657,959,571, and the highest EVAX earnings forecast at -$17,514,452. On average, 6 Wall Street analysts forecast EVAX's earnings for 2027 to be -$463,632,559, with the lowest EVAX earnings forecast at -$751,953,795, and the highest EVAX earnings forecast at -$13,135,839.

In 2028, EVAX is forecast to generate -$255,210,583 in earnings, with the lowest earnings forecast at -$478,144,533 and the highest earnings forecast at -$13,135,839.

If you're new to stock investing, here's how to buy Evaxion A stock.

What is EVAX's revenue growth forecast for 2026-2028?

(NASDAQ: EVAX) Evaxion A's forecast annual revenue growth rate of 4.1% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 31.63%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.01%.

Evaxion A's revenue in 2026 is $7,491,000.On average, 6 Wall Street analysts forecast EVAX's revenue for 2026 to be $0, with the lowest EVAX revenue forecast at $0, and the highest EVAX revenue forecast at $0. On average, 6 Wall Street analysts forecast EVAX's revenue for 2027 to be $0, with the lowest EVAX revenue forecast at $0, and the highest EVAX revenue forecast at $0.

In 2028, EVAX is forecast to generate $4,370,272,723 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $13,496,553,118.

What is EVAX's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: EVAX) forecast ROA is 109.74%, which is higher than the forecast US Biotechnology industry average of 21.27%.

What is EVAX's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: EVAX) Evaxion A's current Earnings Per Share (EPS) is -$0.50. On average, analysts forecast that EVAX's EPS will be -$0.57 for 2026, with the lowest EPS forecast at -$1.58, and the highest EPS forecast at -$0.04. On average, analysts forecast that EVAX's EPS will be -$1.11 for 2027, with the lowest EPS forecast at -$1.80, and the highest EPS forecast at -$0.03. In 2028, EVAX's EPS is forecast to hit -$0.61 (min: -$1.15, max: -$0.03).

What is EVAX's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: EVAX) forecast ROE is 223.14%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.